Alx Oncology Holdings (ALXO) Share-based Compensation Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Alx Oncology Holdings | 189.80 Mn | 49.48 Mn | - | -51.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.90% |
| Dec 31, 2025 | -53.81% |
| Sep 30, 2025 | -63.74% |
| Jun 30, 2025 | -70.55% |
| Mar 31, 2025 | -25.81% |
| Dec 31, 2024 | -12.84% |
| Sep 30, 2024 | -0.17% |
| Jun 30, 2024 | 16.27% |
| Mar 31, 2024 | 10.71% |
| Dec 31, 2023 | 6.77% |
| Sep 30, 2023 | 12.20% |
| Jun 30, 2023 | 6.87% |
| Mar 31, 2023 | 15.45% |
| Dec 31, 2022 | 10.71% |
| Sep 30, 2022 | 48.10% |
| Jun 30, 2022 | 160.89% |
| Mar 31, 2022 | 205.61% |
| Dec 31, 2021 | 226.22% |
| Sep 30, 2021 | 508.27% |
| Jun 30, 2021 | -21.59% |
| Mar 31, 2021 | 1,092.05% |
| Dec 31, 2020 | 2,224.00% |
| Sep 30, 2020 | 701.16% |
| Jun 30, 2020 | 4,655.00% |